179 related articles for article (PubMed ID: 36304254)
1. Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies.
Shao T; Jiang X; Bao G; Li C; Guo C
Dis Markers; 2022; 2022():7571066. PubMed ID: 36304254
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors.
Zhu M; Wang X; Zhang Q; Xie C; Wang T; Shen K; Zhang L; Zhou X
Aging (Albany NY); 2024 Feb; 16(3):2563-2590. PubMed ID: 38315450
[TBL] [Abstract][Full Text] [Related]
3. TPX2 is a prognostic marker and contributes to growth and metastasis of human hepatocellular carcinoma.
Huang Y; Guo W; Kan H
Int J Mol Sci; 2014 Oct; 15(10):18148-61. PubMed ID: 25302620
[TBL] [Abstract][Full Text] [Related]
4. Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer.
Liang B; Zheng W; Fang L; Wu L; Zhou F; Yin X; Yu X; Zou Z
Cancer Biol Ther; 2016 Aug; 17(8):824-32. PubMed ID: 27314162
[TBL] [Abstract][Full Text] [Related]
5. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of TPX2 predicts poor clinical outcome and is associated with immune infiltration in hepatic cell cancer.
Zhu H; Liu J; Feng J; Zhang Q; Bian T; Li X; Sun H; Zhang J; Liu Y
Medicine (Baltimore); 2020 Dec; 99(49):e23554. PubMed ID: 33285774
[TBL] [Abstract][Full Text] [Related]
7. Target protein for Xklp2 (TPX2), a microtubule-related protein, contributes to malignant phenotype in bladder carcinoma.
Yan L; Li S; Xu C; Zhao X; Hao B; Li H; Qiao B
Tumour Biol; 2013 Dec; 34(6):4089-100. PubMed ID: 23873098
[TBL] [Abstract][Full Text] [Related]
8. Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer.
Ma Y; Lin D; Sun W; Xiao T; Yuan J; Han N; Guo S; Feng X; Su K; Mao Y; Cheng S; Gao Y
Clin Cancer Res; 2006 Feb; 12(4):1121-7. PubMed ID: 16489064
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
10. Overexpression of
Bai L; Ren Y; Cui T
J Comput Biol; 2020 Jun; 27(6):965-974. PubMed ID: 31593490
[TBL] [Abstract][Full Text] [Related]
11. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
[TBL] [Abstract][Full Text] [Related]
12. High nuclear TPX2 expression correlates with TP53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability.
Matson DR; Denu RA; Zasadil LM; Burkard ME; Weaver BA; Flynn C; Stukenberg PT
BMC Cancer; 2021 Feb; 21(1):186. PubMed ID: 33622270
[TBL] [Abstract][Full Text] [Related]
13. [miR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression].
Wang J; Liu Z; Dou C; Han S; Li C; Tu K; Yang W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):512-7. PubMed ID: 27053618
[TBL] [Abstract][Full Text] [Related]
14. TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion, and tumor growth of bladder cancer.
Yan L; Li Q; Yang J; Qiao B
J Cell Biochem; 2018 Feb; 119(2):1791-1803. PubMed ID: 28799673
[TBL] [Abstract][Full Text] [Related]
15. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE
Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243
[TBL] [Abstract][Full Text] [Related]
16. TPX2, A novel xenopus MAP involved in spindle pole organization.
Wittmann T; Wilm M; Karsenti E; Vernos I
J Cell Biol; 2000 Jun; 149(7):1405-18. PubMed ID: 10871281
[TBL] [Abstract][Full Text] [Related]
17. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma.
Li G; Wang Z; Chen D; Yin J; Mo Z; Sun B; Yang T; Zhang X; Zhai Z; Li Y; Chen P; Dai Y; Wang Z; Ma J
Front Cell Infect Microbiol; 2022; 12():1025900. PubMed ID: 36204642
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer.
Liu X; Wang W; Chen B; Wang S
Aging (Albany NY); 2024 Apr; 16(8):7188-7216. PubMed ID: 38643462
[TBL] [Abstract][Full Text] [Related]
20. TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.
Liang B; Jia C; Huang Y; He H; Li J; Liao H; Liu X; Liu X; Bai X; Yang D
Dig Dis Sci; 2015 Aug; 60(8):2360-72. PubMed ID: 26025609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
